Dietary Supplements and Aging Muscle

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-02-28

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether older adults (ages 65-89) who consume the dietary supplement Juven (Abbott Laboratories) versus placebo for 6 months will demonstrate increases in fat-free mass, muscle volume,and physical function.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessing the Dose-response of Muscle Protein Synthesis to "Super-whey" in Older Adults

NCT05700058

Sarcopenia

UNKNOWN NA

Nutrition and Exercise for Sarcopenia

NCT00872911

Sarcopenia

COMPLETED PHASE1

Leucine Supplementation Strategies to Enhance Muscle Anabolic Responses in Older Age

NCT06567665

Muscle Protein Synthesis

RECRUITING NA

Enhancing Muscle Health and Metabolism in Pre-frail Middle-aged and Older Adults

NCT05828134

Muscle Loss Muscle Weakness

COMPLETED NA

Protein Supplementation Intervention for Improving Muscle Mass and Physical Performance in Older People With Sarcopenia

NCT04516421

Sarcopenia

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcopenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Juven

Participants in the treatment arm will receive the dietary supplement Juven.

Group Type EXPERIMENTAL

Juven

Intervention Type DIETARY_SUPPLEMENT

Participants in the treatment arm will be asked to consume 2 packets of Juven drink mix each day for a period of six months.

Placebo

Group Type PLACEBO_COMPARATOR

Juven

Intervention Type DIETARY_SUPPLEMENT

Participants in the placebo arm will be asked to consume two packets of an orange-flavored drink mix each day for a period of six months.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Juven

Participants in the treatment arm will be asked to consume 2 packets of Juven drink mix each day for a period of six months.

Intervention Type DIETARY_SUPPLEMENT

Juven

Participants in the placebo arm will be asked to consume two packets of an orange-flavored drink mix each day for a period of six months.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ages 65-89
* Ambulatory

Exclusion Criteria

* Cognitive impairment
* History of renal or hepatic disease
* History of hypotension
* History of peripheral artery disease
* Uncontrolled hypertension
* Uncontrolled diabetes
* Self-reported claustrophobia
* Current smoker
* Steroid or androgen use with the previous 3 months
* Individuals with pacemakers and defibrillators

Minimum Eligible Age

65 Years

Maximum Eligible Age

89 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes